Delivery Order SPE2DB22D1017-SPE2DB24FF3AK
Award Date
2/20/24
Potential Completion Date
2/21/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Estrace 0.01% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,513.26, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 2, 2023. The contract has a completion date of June 5, 2023 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, to provide Estrace 0.01% cream. The contract is a firm fixed price delivery order with a ceiling value of $1,736.50 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp. is the prime contractor for this award, which does not have a set-aside designation. The contract is a part of...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,419.85 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,372.02 firm fixed-price delivery order is for the supply of ESTRACE 0.01% Cream, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of January 12, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,739.91 firm fixed-price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen medication, to support federal healthcare programs. The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,169.91 Firm Fixed Price delivery order is for the supply of Estrace 0.01% cream, a topical estrogen product, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Estrace 0.01% Cream in 42.5 gram units. The $2,002.68 firm fixed-price delivery order is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,778.64 for the supply of Estrace 0.01% Cream 42.5GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, on January 5, 2023, with a completion date of January 6, 2023. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical...
This federal contract award is a delivery order with a ceiling value of $1,311.46, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Estrace 0.01% Cream, 42.5 GM, with a completion date of December 28, 2023. The contract type is Firm Fixed Price, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,315.53 firm fixed price delivery order is for the pharmaceutical product Estrace 0.01% Cream, 42.5 gm. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. This delivery order is associated with a larger $999,999,999 Indefinite Delivery...